ATP5L2 inhibitors are a class of chemical compounds designed to specifically target and modulate the activity of the ATP5L2 protein, a subunit of the ATP synthase complex involved in cellular energy production. ATP synthase is a crucial enzyme complex located in the inner mitochondrial membrane, where it plays a central role in the synthesis of adenosine triphosphate (ATP), the primary energy currency of the cell. ATP5L2 is one of the accessory subunits that contribute to the structural integrity and functional regulation of this complex. Inhibitors of ATP5L2 are designed to interfere with the proper assembly or function of the ATP synthase complex by binding to ATP5L2, potentially disrupting its role in energy production. By targeting ATP5L2, these inhibitors can alter the efficiency of ATP synthesis, providing insights into the regulatory mechanisms of mitochondrial function and energy metabolism.
The development of ATP5L2 inhibitors involves a detailed understanding of the structure and function of the ATP5L2 subunit within the larger ATP synthase complex. Structural biology techniques such as X-ray crystallography and cryo-electron microscopy are employed to visualize the three-dimensional arrangement of ATP5L2, both independently and within the context of the ATP synthase complex. This structural information is crucial for identifying potential binding sites where inhibitors can interact with ATP5L2 to block its function. Computational methods, such as molecular docking and virtual screening, are used to identify chemical compounds that can bind with high affinity to these sites. These candidate inhibitors are then synthesized and subjected to biochemical assays to assess their ability to inhibit ATP5L2's role in the ATP synthase complex. Through iterative rounds of optimization, including structure-activity relationship (SAR) studies, researchers refine these inhibitors to improve their potency, selectivity, and stability. The study of ATP5L2 inhibitors not only contributes to a deeper understanding of the intricate regulation of mitochondrial ATP synthesis but also offers valuable tools for exploring the broader implications of energy metabolism in cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $146.00 $12250.00 | 18 | |
Oligomycin A inhibits ATP synthase by blocking its proton channel, which can indirectly affect ATP5ATP5L2's activity in ATP production. | ||||||
DCC | 538-75-0 | sc-239713 sc-239713A | 25 g 100 g | $71.00 $204.00 | 3 | |
DCCD binds to and inhibits ATP synthase, potentially reducing ATP5ATP5L2 activity by disrupting proton flow across the mitochondrial membrane. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $82.00 $300.00 $1082.00 | 30 | |
Aurovertin B inhibits ATP synthase by binding to its catalytic site, which could hinder ATP5ATP5L2's role in ATP production. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 inhibits V-ATPases, which could indirectly affect ATP5ATP5L2 by altering proton gradients essential for ATP synthase function. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol impacts mitochondrial function and could indirectly inhibit ATP5ATP5L2 by altering mitochondrial dynamics and bioenergetics. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $254.00 | 41 | |
Rotenone inhibits mitochondrial electron transport, which might indirectly affect ATP5ATP5L2 activity by reducing mitochondrial membrane potential. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $54.00 $62.00 $1642.00 $4600.00 | 51 | |
Antimycin A inhibits the electron transport chain, potentially affecting ATP5ATP5L2 by decreasing proton motive force for ATP synthesis. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $42.00 $152.00 $385.00 $845.00 $88.00 | 8 | |
Sodium azide inhibits mitochondrial electron transport, which could indirectly reduce ATP5ATP5L2's activity in ATP production. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $92.00 $348.00 | 46 | |
FCCP uncouples oxidative phosphorylation, potentially affecting ATP5ATP5L2 by disrupting the proton gradient necessary for its activity. | ||||||